Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …

Non-alcoholic fatty liver disease (NAFLD) is regarded as one of the most common liver
pathologies in many societies. Resveratrol, as a phenolic compound with powerful …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …

Abstract Objective Randomized clinical trials (RCTs) examining the effects of resveratrol
supplementation on liver enzymes in non-alcoholic fatty liver disease (NAFLD) have …

Background: Resveratrol, a polyphenol found in various plants, is known for its diverse
bioactivities and has been explored in relation to nonalcoholic fatty liver disease (NAFLD) …

Objective “The obesity epidemic” has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …

Introduction: Cardiovascular disease (CVD) accounts as a major cause of mortality among
patients with nonalcoholic fatty liver disease (NAFLD). Resveratrol, a natural polyphenol …

Non-alcoholic fatty liver disease (NAFLD) is usually associated with insulin resistance,
central obesity, reduced glucose tolerance, type 2 diabetes mellitus and …

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of
chronic liver disease worldwide, directly related to the progressive increase in body weight …